• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Current Drug Shortages L - N

 

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov.  Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A  B  C  D  E  F  G  H  I  K  [L – N]  O  P  Q  R  S  T  U  V  X  Y  Z

Leucovorin Calcium Lyophilized Powder for Injection

** Please note Levoleucovorin (Fusilev) is available in ample quantities**There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg). For more information visit: Spectrum Pharmaceuticals web site.

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Bedford Laboratories
Customer Service
1-800-562-4797 

50 mg (NDC 55390-0005-10)UnavailableShortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website.Other

Revised 4/7/2014

100 mg (NDC 55390-0052-10)Unavailable

Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website.
 

Other
200 mg (NDC 55390-0053-01)Unavailable

Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website.

Other
350mg (NDC 55390-0054-01)AvailableCheck Wholesaler for InventoryOther
500mg Inj Sol VL 50mL solution (NDC 55390-0009-01)Unavailable

Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website.

 

Other
Teva Pharmaceuticals
1-800-545-8800
100mg/vial (NDC 0703-5140-01) 20mL The 100mg has been temporarily discontinued.

See Dear Healthcare Professional letter (PDF 692KB) for additional information.

 

Teva only has the 30ml presentation of Calcium Folinate Solution available, NDC 00703-2797-01.

Regulatory Delay

Revised
3/26/2014
350mg/vial (NDC 00703-5145-01) 30mLTeva 00703-5145-01 Lyophilized Leucovorin is currently on backorder and expected to last through March 2014.
Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300
200 mg SDV (NDC 63323-710-50)Currently on allocation for direct orders.Shortage per Manufacturer:
Manufacturing delays
Demand increase for the drug.

Revised 4/8/2014

500 mg SDV (NDC 63323-711-00)Currently on allocation for direct orders.
Sagent Pharmaceuticals
1-866-625-1618
50 mg vial (NDC 25021-813-10)Available
 
 OtherReverified 4/14/2014
100mg vial (NDC 25021-814-30)Available
 
200mg vial (NDC 25021-815-30)Backorder
350mg vial (NDC 25021-816-30)Available
 

 

Leuprolide Acetate Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Teva
1-800-545-8800
1 mg/0.2 ml (NDC 00703-4014-18)Teva has temporarily discontinued product. Regulatory delay

Reverified
3/26/2014

 
Sandoz
1-609-627-8500
1 mg/0.2 ml (NDC 0781-4003-32)Product now available  Other

Reverified 4/8/2014

Caraco
313-871-8400
1 mg/0.2 ml (NDC 41616-0936-40)On intermittent backorder.Shortage per Manufacturer:
Increase in demand
Demand increase for the drug. 

 

Lidocaine Hydrochloride (Xylocaine) Injection (Initial Posting Date) - 2/22/2012

 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300
Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)Available. Check Wholesalers for inventory.All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available.

Shortage per Manufacturer:
Increase in demand

Demand increase for the drug.Revised 4/8/2014
Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)Backordered. Next release anticipated May 2014. Check wholesalers for inventory. 
Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02Available. Check wholesalers for inventory.
Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)Available. Check wholesalers for inventory.
Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)Backordered. Next release anticipated May 2014. Check wholesalers for inventory.
Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)Available. Check wholesalers for inventory.
Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)Available. Check wholesalers for inventory..
Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)2, 3, 5 month expiry dating available direct by request.
Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)

4 month expiry dating available by request.

Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)Backordered. Check wholesalers for inventory. Next anticipated release April 2014.
Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)Backordered - no release date at this time.
Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)Available. Check Wholesalers for inventory.
Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)Backordered.  Next release anticipated April 2014.
Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)Available. Check Wholesalers for inventory.
Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)Available. Check Wholesalers for inventory.
Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)Available. Check Wholesalers for inventory.
Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)Available. Check Wholesalers for inventory.
Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)Backordered.  Next release anticipated April 2014. Check Wholesalers for inventory.
Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)Available. Check Wholesalers for inventory.

Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)

discontinued

 
Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued 
Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50) – NDC discontinued 
Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)Available. Check Wholesalers for inventory.
Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)Backordered. Check wholesalers for inventory. Next release anticipated April 2014.
 
Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)Available. Check Wholesalers for inventory.
Hospira, Inc.
Customer Service:
1-877-946-7747
 
0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 0409-0996-01)Estimated delivery and recovery: TBD

Please check with your wholesaler for available inventory. 

 

Shortage of Manufacturer: manufacturing delay/Available

OtherRevised 4/13/2014
 
0.5% w/EPI 1:200,000; 50 mL vial (NDC 0409-3177-01)Available
1% w/EPI 1:100,000; 20 mL vial (NDC 0409-3178-01)

Available

1% w/EPI 1:100,000; 30 mL vial (NDC 0409-3178-02)

Available

1% w/EPI 1:100,000; 50 mL vial (NDC 0409-3178-03)

Next delivery May 2014.
Estimated recovery 2Q 2014.

1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-01)Next delivery April 2014.
Estimated recovery 2Q 2014.
1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01)

Available

2% w/EPI 1:100,000; 20 mL vial (NDC 0409-3182-01)

Available

2% w/EPI 1:100,000; 30 mL vial (NDC 0409-3182-02)

Next delivery April 2014

Estimated recovery 2Q 2014

2% w/EPI 1:100,000; 50 mL vial (NDC 0409-3182-03)

Available

2% w/EPI 1:200,000; 20 mL vial (NDC 0409-3183-01)

Available

2% w Epi 1:50,000; 1.8mL syringe (NDC 0409-7263-01)

Estimated delivery and recovery TBD

.0.5%; 50 mL FT  vial (NDC 0409-4275-01)Available
0.5%; 50 mL TT vial (NDC 0409-4278-01)Available
1%; 5mL Ansyr Syringe (NDC 0409-9137-05)

Available

1.5%; 20mL Sterile Pack Amp (NDC 0409-4056-01)

Available

5% w/7.5% Dex; 2mL amp (NDC 0409-4712-01)

Available

1%; 2 mL amp (NDC 0409-4713-32)Available
1%; 20 mL vial (NDC 0409-4276-01)

Available

1%; 30 mL vial (NDC 0409-4279-02)

Available

1%; 50 mL vial (NDC 0409-4276-02)

Available

1%; 30 mL Sterile Pack vial (NDC 0409-4270-01)

Available

2%; 2 mL amp (NDC 0409-4282-01)

Available 

2%; 10 mL amp (NDC 0409-4282-02)Available
1%; 5 mL Abboject syringe (NDC 0409-4904-34)
Available
2%; 5 mL Abboject syringe (NDC 0409-4903-34)

Available

2%; 5 mL vial (NDC 0409-2066-05)

Next delivery June 2014. Estimated recovery 3Q 2014.

2%; 20 mL vial (NDC 0409-4277-01)Available
2%; 50 mL vial (NDC 0409-4277-02)Available 
4%; 5 mL amp (NDC 0409-4283-01)Available
0.4% in 5% Dex; 500mL flex (NDC 00409-7931-24)Next delivery and estimated recovery 2016
0.4% I n5% Dex; 250mL flex (NDC 00409-7931-32)Next delivery and estimated recovery 2016
0.8% in 5% Dex; 250mL flex (NDC 00409-7939-32)Next delivery and estimated recovery 2016
2%; 5mL Ansyr syringe (NDC 0409-1323-05)

Next delivery April 2014
Estimated recovery 2Q 2014

Amphastar Pharmaceuticals, Inc.
Customer Service:
1-800-423-4136

2%, 5mL Luer-Jet Prefilled Syringe
new NDC 76329-3390-1

(old NDC 0548-3390-00)

Amphastar will regularly release products.
 
 Amphastar is  experiencing a product shortage due to an increase in product demand caused by market supply issuesDemand increase for drug 

Revised 3/10/2014


 
American Regent/Luitpold
1-800-645-1706

1%, 50 mL vial package of 25 (NDC 00517-0625-25)

Unavailable - No product available for release. No plan to manufacture.American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USPDiscontinuation of the manufacture of the drug.

Reverified
4/7/2014

2%, 50 mL vial package of 25 (NDC 00517-0626-25)
AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.)
Customer Service:
(732) 839-9400
1-800-645-1706

1% 2 mL Ampoule (NDC 55150-158-72)
 

Available.All presentations are avaialbleDemand increase for the drug.

Reverified
3/18/2014

1% 5 mL Ampoule (NDC 55150-159-74)
2% 2 mL Ampoule (NDC 55150-160-72)
1% 2 mL
Single Dose Vial
(NDC 55150-161-02)
1% 5 mL
Single Dose Vial
(NDC 55150-162-05)
1% 30 mL
Single Dose Vial
(NDC 55150-163-30)
2% 2 mL
Single Dose Vial
(NDC 55150-164-02)
2% 5 mL
Single Dose Vial
(NDC 55150-165-05)

 

 

Liotrix (Thyrolar) Tablets

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Forest Pharmaceuticals
1-800-678-1605

Thyrolar-1/4
(NDC 0456-0040-01)

Product currently unavailable; estimated duration: 1 yearShortage per Manufacturer:
Due to shortage of the T3 component of the formulation Forest cannot provide anticipated release date
 
Shortage of an active ingredientReverified 3/18/2014 

Thyrolar-1/2
(NDC 0456-0045-01)

Thyrolar-1
(NDC 0456-0050-01)

Thyrolar-2
(NDC 0456-0055-01)

Thyrolar-3
(NDC 0456-0060-01) 

 

Lorazepam (Ativan) Injection 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
 

2 mg/mL, 1 mL vial
(NDC 0641-6001-25)

West-Ward currently has inventory for most Ativan/Lorazepam Injection, USP presentations.

The Lorazepam 2 mg/mL, 10 mL vial, 4 mg/mL 1 mL and 10 mL vials are experiencing a temporary backorder situation.

West-Ward has accelerated production on all Ativan/Lorazepam Injection codes. 

West-Ward is anticipating manufacturing additional lots with releases expected in February 2013.
Product will be made available as it is released.

 

Demand increase for the drug

Revised 1/28/2014


 


 


 


 


 


 


 

2 mg/mL, 10 mL vial
(NDC 0641-6000-10)

 

4 mg/mL, 1 mL vial
(NDC 0641-6003-25)

 

 

4 mg/mL, 10 mL vial,
(NDC 0641-6002-10)

 

 

2 mg/mL, 1 mL vial
(NDC 0641-6044-25)

 

 

2 mg/mL, 10 mL vial,
(NDC 0641-6046-10)

 

 

4 mg/mL, 1 mL vial
(NDC 0641-6045-25)

 

 

4 mg/mL, 10 mL vial,
(NDC 0641-6047-10)

 

 

Hospira Inc. Customer Service:
1-877-946-7747

2 mg/mL; 1 mL vial
(NDC 0409-6778-02)

Available

Please check with your wholesaler for available inventory.

 

Shortage per Manufacturer:
Manufacturing delay/Available


 

 

Demand increase for the drug/Other

Reverified 4/13/2014

2 mg/mL; 10 mL vial
(NDC 0409-6780-02)

Next delivery May 2014.
Estimated recovery 2Q 2014

2 mg/mL; 1 mL Carpuject syringe
(NDC 0409-1985-30)

Next delivery April  2014.
Estimated recovery 2Q 2014 

2 mg/mL; 1 mL iSecure syringe
(NDC 0409-1985-05)

Discontinued

4 mg/mL; 1 mL vial
(NDC 0409-6779-02)

Early June 2014
Estimated recovery: 2Q 2014

4 mg/mL; 10 mL vial
(NDC 0409-6781-02)

Available

4 mg/mL; 1 mL
Carpuject syringe (NDC 0409-1539-31)

Available

Akorn Pharmaceutical:
1-800-932-5676
 

2 mg/mL, 1 mL vial
(NDC 17478-0040-01)

Available  

 NA

 

Other 

Revised
4/16/2014

Amphastar Pharmaceuticals, Inc./IMS
Customer Service:
1-800-423-4136
 
2mg/mL, 10 mL Vial (NDC 76329-8261-1)Available  Revised 3/10/2014

  

Magnesium Sulfate Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300
 
500 mg/mL, 2 mL vial (NDC 63323-0064-02)

Available. Check wholesalers for inventory.

Check wholesalers for inventory.  Shortage per Manufacturer:
Increased demand for the product.

Demand increase for the drug. Revised 4/8/2014
500 mg/mL, 10 mL vial (NDC 63323-0064-10)

Available. Check wholesalers for inventory.

500 mg/mL, 20 mL vial (NDC 63323-0064-20)

Available. Check wholesalers for inventory.

500 mg/mL, 50 mL vial (NDC 63323-0064-50)

Backordered. Next release anticipated May 2014. Check wholesalers for inventory.

American Regent/Luitpold
1-800-645-1706
500 mg/mL, 2 mL vial pkg of 25(NDC 00517-2602-25)Unavailable. No product available for release. No plan to manufactureAmerican Regent is currently not releasing Magnesium Sulfate Injection.OtherReverified 4/7/2014
500 mg/mL, 10 mL vial pkg of 25(NDC 00517-2610-25)
500 mg/mL, 50 mL vial pkg of 25(NDC 00517-2650-25)
Hospira, Inc. Customer Service
1-877-946-7747

      

50%; 20 mL vial

(NDC 0409-2168-02)

Limited supply available

Please check with your wholesaler for available inventory. 

 

Shortages per Manufacturer: manufacturing delay; Available

Other 

Revised 4/13/2014

50 %; 10 mL Ansyr syringe

(NDC 0409-1754-10)

Next delivery mid May 2014. Estimated recovery 2Q 2014

40 mg/mL-water; 50 mL bag

(NDC 0409-6729-24)

Next delivery mid April 2014. Estimated recovery 2Q 2014

40 mg/mL-water; 100 mL bag

(NDC 0409-6729-23)

Available

40 mg/mL-water; 500 mL bag

(NDC 0409-6729-03)

Available

40 mg/mL-water; 1000 mL bag

(NDC 0409-6729-09)

Available

10 mg/mL-dextrose; 100 mL bag

(NDC 0409-6727-23)

Available

80 mg/mL-water; 50 mL bag

(NDC 0409-6730-13)

Available

 

Mannitol (Osmitrol, Resectisol) Injection (Initial Posting Date) - 12/21/2011

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300

 

250 mg/mL, 50 mL vial, 25 count
(NDC 63323-0024-25)
Available.
 Check wholesalers for inventory.
Available
Shortage per Manufacturer:
Increase demand
Demand increase for the drug. Reverified 4/8/2014
B. Braun Medical Inc.
Customer Service:
1-800-227-2862
20% Mannitol Injection USP
500 mL flexible plastic container NDC 0264-7578-10 
All presentations available. 

 

Other 

Unable to verify as of
10/25/2013 

250 mL flexible plastic container NDC 0264-7578-20
Hospira, Inc.
Customer Service
1-877-946-7747
25%; 50 mL vial
(NDC 0409-4031-01)

Available 

Please check with your wholesaler for all available inventory.

Shortage per Manufacturer:
Available

Other Reverified 4/13/2014
20%; 250 mL container
(NDC 0409-7715-02)
Available
20%; 500 mL container
(NDC 0409-7715-03)

Available

American Regent/Luitpold
1-800-645-1760
25%,  50 mL vial package of 25
(NDC 0517-4050-25)
Unavailable - No product available for release. No plan to manufactureAmerican Regent is currently not releasing Mannitol Injection.Shortage of an inactive ingredient component

Reverified
4/7/2014

Baxter Customer Service:
1-800-ANA-DRUG
(1-800-262-3784)
20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-02All presentations available. OtherReverified 3/17/2014
20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-03

 

Mecasermin [rDNA origin] (Increlex) Injection (Initial posting – 4/26/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Ipsen
Biopharmaceuticals
Inc.

Contact:
1-855-463-5127

INCRELEX
(mecasermin [rDNA origin] injection), 10 mg/mL
NDC-15054-1040-5
Ipsen
Biopharmaceuticals Inc. has limited product available and cannot estimate a release date for a new batches.

Shortage per manufacturer: Relocation
of the third party manufacturing site.

Ipsen Biopharmaceuticals, Inc.
(Ipsen) has been working with the Food and Drug Administration (FDA) in efforts to minimize any supply disruption. Current lots of Increlex in the marketplace were manufactured using an alternative drug substance manufacturing facility that has not been approved by the
FDA.

For more information on this release of supply, see Dear Healthcare Professional Letter (PDF - 49KB).

For more information regarding the anticipated drug shortage for Increlex, see Dear
Healthcare Professional Letter (PDF -  142KB)
.

Contact Ipsen Biopharmaceuticals Inc. regarding product availability. 

Shortage of the active ingredient

Reverified 4/1/2014 

 

Methazolamide (Glauctabs, Neptazane) Tablets (Initial posting – 6/29/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated


Perrigo Customer Service 
1-866-634-9120

25 mg, 100s (NDC 48102-0100-01)
UnavailableExpected to be available to resume shipments in March 2014.OtherRevised 2/21/2014
50 mg, 100s (NDC 48102-0101-01)
Neptazane- 25 mg, 90s (NDC 48102-0014-90)
Neptazane- 50 mg, 90s (NDC 48102-0015-90)

Sandoz
Customer Service:
1-609-627-8500

25 mg, 100s (NDC 0781-1072-01)Due to an API shortage, product will go on back order until June 2014API delayShortage of an active ingredient

Reverified 4/8/2014
 

25 mg, 1000s (NDC 0781-1072-10)
50 mg, 100s (NDC 0781-1071-01)
50 mg, 1000s (NDC 0781-1071-10)

 

Methyldopate Hydrochloride Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

American Regent, Inc./Luitpold:

1-800-645-1706

50 mg/mL, 5 mL vial, 10s (NDC 00517-8905-10)Unavailable - No product available for release. No plan to manufactureAmerican Regent is currently not releasing Methyldopate HCl Injection, USP.Shortage of active ingredientReverified 4/7/2014

 

Methylin Chewable Tablets (Initial Posting Date – 2/19/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Shionogi Pharma, Inc.:
(973) 966-6900
2.5 mg tablets (NDC 59630-760-10)
100 package size
Product temporarily unavailable.Shortage per Manufacturer: Manufacturing issues.OtherReverified 3/25/2014 
5 mg tablets (NDC 59630-761-10) 
100 package size
10 mg tablets (NDC 59630-762-10) 
100 package size

 

Methylphenidate Hydrochloride ER Tablets (Initial Posting Date – 2/19/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Mallinckrodt Customer Service:
1-800-325-8888
10 mg ER tablets (NDC 00406-1145-01) 
100 package size
Available OtherReverified 3/25/2014 
20 mg ER tablets (NDC 00406-1473-01)
100 package size
 
Sandoz
Customer Service: 1-609-627-8500
20 mg Sustained-Release, 100s (NDC 00781-5754-01)Will go on backorder this week. Shortage of an active ingredient, Manufacturing site capacity, Active ingredient availability.Delay in shipping of the drugRevised 4/8/2014
UCB, Inc.
Customer Service: 800-477-7877
20 mg Methylphenidate ER, 100s (NDC 53014-594-07)

Available

 Demand increase for the drugReverified 4/8/2014
Actavis, Inc.
1-800-272-5525
Methylphenidate Hydrochloride, ER Capsules,  20 mg, 100s
(NDC: 67767-0200-01)
AvailableNo supply issues anticipatedOtherRevised 1/13/2014
Methylphenidate Hydrochloride, ER Capsules, 30 mg, 100s
(NDC: 67767-0201-01)
Available
Methylphenidate Hydrochloride, ER Capsules, 40 mg, 100s
(NDC: 67767-0202-01)
Available
Methylphenidate Hydrochloride, ER Tablets, 18 MG 100s
(NDC: 00591-2715-01)
Available
Methylphenidate Hydrochloride, ER Tablets, 27 MG 100s
(NDC: 00591-2716-01)
Available

Methylphenidate Hydrochloride, ER Tablets, 36 MG 100s
(NDC: 00591-2717-01)

Available
Methylphenidate Hydrochloride, ER Tablets, 54 MG 100s
(NDC: 00591-2718-01)
Available
Teva Pharmaceuticals
 1-800-545-8800
20mg, 100 count (NDC 0093-5346-01)Teva has Methylphenidate Hydrochloride ER Capsules on back order and the company cannot estimate a release date.Shortage per Manufacturer: Recall initiated due to a routine stability failureOtherReverified 3/26/2014
30mg, 100 count (NDC 0093-5347-01)
40mg, 100 count (NDC 0093-5348-01)

 

Methylphenidate Hydrochloride Tablets (Initial Posting Date – 2/19/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Mallinckrodt Customer Service:
1-800-325-8888
5 mg IR tablets (NDC 00406-1142-10)
1000 package size 

Available

 OtherReverified 3/25/2014 
10 mg IR tablets (NDC 00406-1144-01 and 00406-1144-10), 100 and 1000 package size
20 mg IR tablets (NDC 00406-1146-01 and 00406-1146-10), 100 and 1000 package size

Available

UCB, Inc.
Customer Service: 1-800-477-7877
20 mg Methylphenidate Hydrochloride IR tablets, 100 tabs (NDC 53014-532-07)

Available

 Demand increase for drug.Reverified
4/8/2014

 

 
10 mg Methylphenidate IR Tablets - 100 tabs (NDC 53014-530-07)Available
5 mg Methylphenidate IR tablets- 100 tabs (NDC 53014-0531-07)Available
Sandoz
Customer Service: 1-609-627-8500
 
 
 
 
 
 
 
 
 
 
 

5 mg, 100s (NDC 00781-5748-01)

 

Product now on back order until Mid-April 2014
 

Shortage per Manufacturer: Manufacturing site capacity, Active ingredient availability

 

Shortage of an active ingredient. 

 

Revised 4/8/2014

 

 

 

 

 

 

 

10 mg, 100s (NDC 00781-5749-01)

 

 

Currently on back order. 

Shortage per Manufacturer: Manufacturing site capacity/API availability

Shortage of an active ingredient

 

20 mg, 100s (NDC 00781-5753-01)We are currently on back order.   
Actavis, Inc.
1-800-272-5525
Methylphenidate Hydrochloride Tablets, USP, 5 mg,
NDC: 0591-5882-01
Available No supply issues anticipatedOtherRevised 1/13/2014 
Methylphenidate Hydrochloride Tablets, USP, 10 mg,
NDC: 0591-5883-01
Methylphenidate Hydrochloride Tablets, USP, 20 mg,
NDC: 0591-5882-01

 

Methylprednisolone Sodium Succinate Injection (Initial Posting - 2/14/2014)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Pfizer
Customer Service:
1-800-533-4535 

Solu-Medrol 40mg Act-O-Vial 25's (NDC 0009-0039-28) 

Full recovery estimated 9/15/2014

 

Full recovery estimated 7/1/14 for NDC 0009-0039-28
 
Full recovery estimated 5/5/14 for NDC 0009-0039-32
 
Full recovery estimated 7/1/14 for NDC 0009-0047-22
 

Full recovery estimated 4/7/14 for NDC 0009-0047-26

 

 Revised
4/11/2014 
Solu-Medrol 40mg Act-O-Vial 25's (Novaplus) NDC 0009-0039-32 Full recovery estimated 4/21/2014
Solu-Medrol 125mg Act-O-Vial 25's NDC 0009-0047-22 Full recovery estimated 8/25/2014
Solu-Medrol 125mg Act-O-Vial 25's (Novaplus) NDC 0009-0047-26Full recovery estimated 5/1/2014
Solu-Medrol 500mg MD Vial 1's NDC 0009-0758-01Available 

Solu-Medrol 500mg Act-O-Vial 1's NDC 0009-0003-02
Solu-Medrol 1g MD Vial 1's NDC 0009-0698-01 
Solu-Medrol 1g Act-O-Vial 1's NDC 0009-0018-20 
Solu-Medrol 2g MD Vial 1's NDC 0009-0796-01

    

Morphine Sulfate (Astramorph PF, Duramorph, Infumorph) Injection (Preservative Free)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300 
Astramorph PF
0.5 mg/mL 2 mL ampule, 10 count (NDC 63323-0291-80)
 
Fresenius Kabi has PF Astramorph on back order

Shortage per Manufacturer:
Manufacturing delay

OtherReverified 4/8/2014
Astramorph PF
0.5 mg/mL 10 mL vial, 5 count (NDC 63323-0291-10)
Astramorph PF
1 mg/mL 2 mL ampule, 10 count (NDC 63323-0292-80)
Astramorph PF
1 mg/mL, 10 mL vial (NDC 63323-0292-10)
Hospira, Inc.
Customer Service:
1-877-946-7747
0.5 mg/mL; 10 mL vial (NDC 0409-3814-12) 

Next delivery May 2014
Estimated recovery 2Q 2014
 

Shortage per manufacturer: Manufacturing delay / Available

Other

Revised 4/13/2014
1 mg/mL; 10 mL vial (NDC 0409-3815-12)

Available

50 mg/mL; 20 mL vial (NDC 0409-1134-03)Next delivery May 2014
Estimated recovery 2Q 2014
 

25 mg/mL; 1 mL vial (NDC 0409-1135-02)

Next delivery June 2014. Estimated recovery 2Q 2014

2mg/mL; 1mL Carpuject (NDC0409-1890-01

Available

New preservative-free product to replace preserved product NDC 0409-1762-30
4mg/mL; 1mL Carpuject (NDC 0409-1891-01)

Available

New preservative-free product to replace preserved product NDC 0409-1258-30
8mg/mL; 1mL Carpuject (NDC 0409-1892-01)AvailableNew preservative-free product to replace preserved product NDC 0409-1260-69
10mg/mL; 1mL Carpuject (NDC 0409-1893-01)

Available

New preservative-free product to replace preserved product NDC 0409-1261-30
15mg/mL; 1mL Carpuject (NDC 0409-1894-01)AvailableNew preservative-free product to replace preserved product NDC 0409-1264-31
West-Ward Pharmaceuticals Customer Service:
1-800-631-2174
 

Infumorph
20 mL ampul, 10 mg/mL
(NDC 0641-6039-01)

Available
West-Ward has accelerated production on this product.  

West-Ward is anticipating having additional lots of each product code available in the January – February 2014 timeframe.
Product will be made available as it is released.
 

Demand increase for the drug.Revised 1/28/2014

Infumorph
20 mL ampul, 25 mg/mL
(NDC 0641-6040-01)

Duramorph
10 mL ampul, 1 mg/mL)
(NDC 0641-6019-10)

Available
West-Ward has accelerated production on this product. 

Duramorph
10mL ampul, 0.5 mg/mL
(NDC 0641-6020-10)

BD Rx Inc. Customer Service:
866-943-8534 

2 mg/mL single-use Pre-filled syringe (Preservative-Free)
(NDC 76045-004-10) 

Available 

Please check with your wholesaler for available inventory 

 

 

OtherRevised 4/8/2014

4 mg/mL single-use Pre-filled syringe (Preservative-Free)
(NDC 76045-005-10) 

Estimate availability Early 2014 
 
Scaling up for launch

5 mg/mL single-use Pre-filled syringe (Preservative-Free)
(NDC 76045-006-10) 

Estimate availability Early 2014
 
Scaling up for launch

8 mg/mL single-use Pre-filled syringe (Preservative-Free)
(NDC 76045-007-10) 

Estimate availability Early 2014Scaling up for launch
 
10 mg/mL single-use Pre-filled syringe (Preservative-Free)
(NDC 76045-008-10) 
Estimate availability Early 2014
 
Scaling up for launch
Amphastar Pharmaceuticals Inc. Customer service:
1-800-423-4136 

Morphine sulfate inj. USP 1mg/mL, 30 mL PCA Vial, NDC 0548-1911-25, new NDC 767329-1911-1

Available

 

 

 

 Revised 3/10/2014

 

Multi-Vitamin Infusion (Adult and Pediatric)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira , Inc.
Customer Service
1-877-946-7747
MVI-12 Adult; 10 mL vial (NDC 61703-423-81)Adult formulations:  temporarily suspended production.
 

Shortage per Manufacturer:
Adult formulations temporarily suspended production.

 

Shortage per Manufacturer:
Pediatric formulation-Available

OtherReverified 4/13/2014
MVI-12 Adult; 2x50 mL PBP(NDC 61703-423-83)
MVI Adult; 10 mL vial (NDC 61703-422-81)
MVI Adult; 2x5 mL (NDC 61703-422-82)
MVI Adult 2x50 mL PBP (NDC 61703-422-83)
MVI Pediatric; 5 mL vial (NDC 61703-421-53)

Available

Baxter (Infuvite adult and pediatric IV solution)
Customer Service:
1-888-229-0001

INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)

Pediatric Single Dose is not available.

Baxter is the distributor of INFUVITE Multiple Vitamins for Injection. Baxter has these products on allocation and is working with the manufacturer to maximize the availability of INFUVITE Multi Vitamins.
 

 

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition disclaimer icon 

Requirements related to complying with good manufacturing practices.Reverified 3/17/2014
INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)Baxter has this product on allocation.
INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)Baxter has this product on allocation.
INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5649-2)Baxter has this product on allocation.

 

Nalbuphine HCl (Nubain) Injection (Initial Posting - 5/15/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc.
Customer Service:
1-877-946-7747
10 mg/mL; 1 mL ampule (NDC 0409-1463-01)

Next delivery September 2014
Estimated recovery 3Q 2014
 

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Manufacturing delay; Available

Other Reverified
4/13/2014
10 mg/mL; 10 mL vial (NDC 0409-1464-01)

Available 

20 mg/mL; 1 mL ampule (NDC 0409-1465-01)

Available

20 mg/mL; 10 mL vial (NDC 0409-1467-01)

Available

 

Neostigmine Methylsulfate Injection, USP (Initial Posting - 1/14/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Fresenius Kabi, USA
(Formerly APP Pharmaceuticals, LLC)
1-888-386-1300 
0.5 mg/mL,  5 mg/10 mL MDV (NDC # 63323-382-10)

Available.
Check wholesaler for inventory.

 

Demand increase for the drug.

Revised 4/8/2014 

1 mg/mL, 10 mg/10 mL MDV

(NDC # 63323-383-10)
 

Backordered. Check wholesaler for inventory. Next release anticipated May 2014

American Regent/Luitpold
1-800-645-1706

1 mg/mL, 10 mL vial, package of 25 (NDC 00517-0033-25)

 Unavailable

American Regent is currently not releasing Neostigmine Methylsulfate Injection 0.5 mg/mL or 1 mg/mL
 

Other

Reverified 12/9/2013

0.5 mg/mL, 10 mL vial, package of 25 (NDC 00517-0034-25)

Unavailable
Éclat Pharmaceuticals
(636) 449-1832

Bloxiverz (neostigmine methylsulfate injection, USP), 0.5 mg/mL, (NDC 76014-002-33) and (NDC 76014-002-10)

Available and in full supply at all of the wholesalers

 

Bloxiverz is the first & only FDA-Approved neostigmine methylsulfate injection product available

Other

Reverified 4/8/2014

Bloxiverz (neostigmine methylsulfate injection, USP), 1 mg/mL, (NDC  76014-003-33) and (NDC 76014-003-10)

Available and in full supply at all of the wholesalers

 

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174

 

0.5 mg/mL, 10 mL vial (NDC 0641-6076-10)
 

1  mg/mL, 10 mL
vial (NDC 0641-6077-10)

West-Ward currently has limited quantities available for both presentations.  West-Ward has accelerated production on this product.
 

West-Ward is manufacturing additional lots and anticipates having product available in the April - May 2014 timeframe.
Product will be made available as it is released.

Demand increase for the drug.

Revised 3/30/2014 

 

Nitroglycerin in 5% Dextrose Injection, USP (Initial Posting - 12/20/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Baxter Healthcare Customer Service:
1-888-229-0001

25 mg Nitroglycerin in 5% Dextrose Injection; code 1A0692 (0338-1047-02)

Baxter has this product on allocation.
Estimated recovery: April 6, 2014.
 Demand increase for the drugRevised 3/28/2014
50 mg Nitroglycerin in 5% Dextrose Injection; code 1A0694 (0338-1049-02)
100 mg Nitroglycerin in 5% Dextrose Injection; code 1A0696 (0338-1051-02)
Hospira, Inc.
Customer Service: 1-877-946-7747
200 mcg/mL; 250 mL bottle
(NDC 0409-1482-02)
 Next delivery and estimated recovery 3Q 2014 

Shortage of Manufacturer:  
Manufacturing delay

OtherReverified 4/13/2014
100 mcg/mL; 250 mL bottle
(NDC 0409-1483-02)
100 mcg/mL; 500 mL bottle
(NDC 0409-1483-03)
400 mcg/mL; 250 mL bottle
(NDC 0409-1484-02)

back to top of page

Current Drug Shortages Index